CDI Institute

Fujifilm Cellular Dynamics (formerly Cellular Dynamics International) is a global leader in the development and manufacture of human induced pluripotent stem cell (iPSC) technologies. The company provides a vast portfolio of high-quality, human-derived cells for drug discovery, toxicity testing, and regenerative medicine applications. Beyond its role as a supplier, the company operates as a contract development and manufacturing organization (CDMO) to support the clinical translation of cell therapies. Its internal pipeline focuses on high-unmet-need areas such as Parkinson's disease and cardiovascular disorders, leveraging its proprietary iPSC platform to create standardized, off-the-shelf therapeutic solutions.